Structure-Based Stepwise Screening of PPARγ Antagonists as Potential Competitors with NCOA1 Coactivator Peptide for PPARγ CIS Site
Authors:
- 27 October 2018
- journal article
- research article
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 25 (4) , 1369-1377
Abstract
No abstract availableKeywords
Funding Information
- the Medicine and Health Project of Zhejiang (2015KYA241)
- the B-Class Project of Enze Group (15EZB2)
- the A-Class Project of Taizhou Science and Technology Bureau (14SF07)
This publication has 44 references indexed in Scilit:
- Fast and reliable prediction of domain–peptide binding affinity using coarse-grained structure modelsBioSystems, 2013
- Identification of PPARgamma Partial Agonists of Natural Origin (I): Development of a Virtual Screening Procedure and In Vitro ValidationPLOS ONE, 2012
- The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseasesJournal of Advanced Pharmaceutical Technology & Research, 2011
- PPARγ: a circadian transcription factor in adipogenesis and osteogenesisNature Reviews Endocrinology, 2010
- Rapid Context-Dependent Ligand Desolvation in Molecular DockingJournal of Chemical Information and Modeling, 2010
- Discovery and development of selective PPARγ modulators as safe and effective antidiabetic agentsExpert Opinion on Investigational Drugs, 2010
- Automated Docking Screens: A Feasibility StudyJournal of Medicinal Chemistry, 2009
- Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interfaceNature, 2007
- Discovery of Small-Molecule Inhibitors of the NFAT−Calcineurin Interaction by Competitive High-Throughput Fluorescence Polarization ScreeningBiochemistry, 2004
- Do Structurally Similar Molecules Have Similar Biological Activity?Journal of Medicinal Chemistry, 2002